Web Research
Web Research — What the Internet Knows
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The Bottom Line from the Web
Two days before this research was pulled, Elixirr launched a $15.9m secondary share placing "to meet heightened institutional demand" — a placing that comes immediately after the FY2025 annual report and against a stock that has slid 17.8% from its September 2025 high of $12.18 (905.6p). The web reveals a company that is simultaneously executing (revenue $201.5m beat the $200.6m forecast, EPS beat consensus, ninth bolt-on acquisition closed, graduated from AIM to the LSE Main Market in July 2025) and pricing risk (analyst consensus target of $15.10 sits roughly 53% above spot, while the founder/CEO has been a steady seller and EV/EBITDA at 13× sits comfortably above the 6–10× boutique-consulting norm). The placing is the headline event the filings can't tell you about — it changes the float, dilutes existing holders, and signals that the company is taking the cash institutions are offering rather than waiting for a higher price.
What Matters Most
1. $15.9m secondary share placing launched ~29 April 2026 to broaden institutional base
Elixirr launched a $15.9 million secondary share placing within the past 48 hours, structured "to match heightened interest from qualified investors following Elixirr's recent performance updates" and to broaden the institutional shareholder base. This is a placing of existing shares, not a primary issuance — it relieves selling holders rather than raising fresh capital. (Source: Globe and Mail / TipRanks, 29-Apr-2026.) Given the stock was already 17.8% off its high and the placing prices into a soft tape, an investor needs to know who sold — the founder has been the most active seller historically — and whether the lock-up arrangements indemnify against further supply.
2. FY2025 results beat — revenue $201.5m, EPS beat, dividend on track
Elixirr reported FY2025 revenue of $201.5m vs $200.6m consensus (+34% YoY from $139.5m), with EPS also exceeding expectations. The 2025 Annual Report was published on the FCA National Storage Mechanism on ~29-Apr-2026, with paper copies due ~25-May-2026. Q3 2025 (interim) had already pre-printed the trajectory: 0.29p EPS vs 0.22p consensus — a ~32% beat. (Sources: Investing.com transcript, 24-Apr-2026; MarketScreener; TipRanks; Investegate.) The market's tepid reaction (still 17.8% off the September peak) suggests the beat was already priced in and forward guidance is what is being discounted.
3. Stock drawdown of ~17.8% from $12.18 peak (Sep 30, 2025) — divergence from fundamentals
ELIX traded at $9.85 at the most recent FT print, 17.83% below the 52-week high of $12.18 (905.63p) set on 30-Sep-2025 (also the all-time high per TradingView; the all-time low was $2.32 (188p) on 15-Jul-2020). The 12-month range is $7.82–$12.18 (580p–905.6p). The drawdown coincided with the September peak that itself coincided with the TRC Advisory acquisition announcement and the LSE Main Market move — meaning the price tells a different story than the operating numbers. (Sources: FT.com; TradingView; ADVFN.)
4. TRC Advisory acquisition (Sep 22, 2025) — largest ever, 9th total, 5th in the US
Elixirr announced the acquisition of TRC Advisory, LLC on 22-Sep-2025 — its largest deal to date, seventh since the 2020 AIM IPO, first since joining the LSE Main Market in July 2025, and fifth US acquisition. The deal was described as immediately earnings-enhancing. The cumulative roll-up now totals nine boutiques: Den Creative, Coast Digital, The Retearn Group, iOLAP ($40m, Mar-2022), Responsum, Insigniam, Hypothesis (Oct-2024), TRC Advisory (Sep-2025) and Kvadrant Consulting. (Sources: BusinessWire; Stockopedia/RNS; Investegate.) M&A is therefore the dominant capital-allocation activity — and explains the credit facility expansion and the share placing.
5. Credit facility expanded to $87.4m (Sep 2025) explicitly to fund more M&A and limit dilution
Elixirr expanded its revolving credit facility to $87.4m in September 2025 with the stated purpose of "supporting M&A growth strategy, limiting dilution." (Source: TipRanks, 18-Sep-2025.) Read against the $15.9m placing seven months later, the "limit dilution" framing has clearly bent — the company is using both debt and equity to keep the deal cadence going.
6. Promotion to the LSE Main Market in July 2025 — uplisting from AIM
Elixirr moved from AIM to the LSE Main Market in July 2025. This is the single biggest structural event of the past 12 months: it widens the eligible institutional buyer pool (many UK funds cannot hold AIM stocks), increases regulatory burden, and subjects the firm to UK Corporate Governance Code rather than the lighter QCA Code. The web framing across multiple sources is consistently positive ("expanding global challenger consultancy model"). (Sources: TipRanks, Investegate, BusinessWire 22-Sep-2025.)
7. Analyst consensus is constructive — target $15.10 vs $9.85 spot (~53% upside)
19 sell-side analysts have a consensus Buy rating; the consensus 12-month price target is $15.10 with a range of $13.90–$16.82 (TradingView). Bitget cites a +47% one-year forecast ($13.56). Stockopedia puts trailing P/E at 10.76x; stockanalysis.com puts trailing P/E at 24.78x and forward P/E at 16.03x — the gap reflects ambiguity around what counts as adjusted EPS post-acquisition amortisation. EV/EBITDA is 13.11x and EV/FCF is 12.76x.
8. Insider buy by Simon Retter (Feb 24, 2026) — but founder has been a net seller
A small but recent positive: insider Simon Retter purchased 1,476 shares at $9.12 (677p) on 24-Feb-2026 (~$13.5k commitment). (Source: The Cerbat Gem.) Set against this, Simply Wall St (19-Jan-2025) flagged that Founder/CEO Stephen Newton has been selling, and TipRanks shows aggregate 3-month insider buying of only ~$3.4k. Founder ownership has stepped down across the disclosed snapshots: 29% (Oct-2022) → 25% (Jan-2025) → 24% (Dec-2025) — directionally consistent with founder profit-taking, even though absolute insider control remains very high (~42%).
9. CFO promoted to Deputy CEO; new CFO appointed (Dec 2024 / early 2025)
Co-founder Graham Busby was promoted from CFO to Deputy CEO in early 2025, with a replacement CFO named in the December 2024 announcement. (Sources: MarketScreener, 10-Dec-2024; Board of Directors page, 30-Jan-2026.) Busby has personally led the eight-acquisition build, so the elevation tightens M&A control at the executive level — and signals that the inorganic strategy is the next leg, not a one-off.
10. Margin compression in FY2024 (which the FY2025 results need to have reversed)
FT.com flags that in FY2024, net income fell 4.98% ($21.9m → $20.5m) despite revenue growth of 29.64% — cost of goods sold rose from 65.93% to 67.84% of sales. This is the financial pattern most often associated with margin-dilutive M&A integration. The FY2025 EPS beat suggests this has been worked through, but the FY2024 print is the reason valuation multiples compressed during 2H 2025.
11. Clean reputational record — no SEC, Reuters or CNBC controversy hits
Repeated specialist queries for "scandal", "controversy", "investigation" and "SEC" returned no substantive matches across Reuters, CNBC and broader press. The Reuters company page exists with metadata only; CNBC explicitly states "There is no recent news for this security." Yahoo Finance shows ISS Governance QualityScore as N/A — no negative governance flag, but also no positive third-party assurance. (Sources: Reuters; CNBC; Yahoo Finance.)
12. Industry tailwind is real but Elixirr is a 0.04% slice of a $374B market
The global management consulting services market is $374.67bn in 2026, growing at a 4.7% CAGR to $471bn by 2031 (Mordor Intelligence). North America held 37.45% of the market in 2025. Tier-1 and tier-2 firms (McKinsey, BCG, Bain, Deloitte, KPMG, Accenture) account for ~60% of share. The 2026 trend narrative is dominated by AI/ML embedded in consulting offerings — Elixirr's pitch is consistent with this and its acquisitions (iOLAP, Hypothesis, TRC) align to data, insights and transformation. (Sources: Mordor Intelligence; Six Paths Consulting; IBISWorld.) The runway is huge, but the specific share gains require continued execution against giants.
Recent News Timeline
What the Specialists Asked
Insider Spotlight
CEO Newton Stake
Total Insider Ownership
Boutique Acquisitions
Credit Facility ($M)
Stephen Newton — Co-founder & CEO. Largest individual shareholder at ~24% (down from 29% at Oct-2022, 25% at Jan-2025). Has been a steady net seller across the disclosed snapshots. Founded the firm in 2009 after frustration with traditional consulting's "stagnated approach to innovation."
Graham Busby — Co-founder & Deputy CEO (former CFO). Promoted to Deputy CEO in early 2025. Personally owns the inorganic-growth agenda, having overseen all eight (now nine) acquisitions to date. The promotion structurally elevates the M&A engine.
Gavin Patterson — Chairman (since 2019). Former CEO of BT Group 2013–2018, where he led the UK superfast and ultrafast fibre rollouts. High-profile Chair brings governance credibility and likely opens doors at the FTSE-listed client tier.
Simon Retter — insider (purchased 1,476 shares at $9.12 on 24-Feb-2026 ~ $13.5k). The only confirmed insider buy on record in the past several months — small in dollar terms but the only positive directional signal from the insider class.
Charlotte (NED, July 2020). Independent Non-Executive Director, prior consulting relationship from April 2020.
Comprehensive Form-4-style disclosure is not available because Elixirr is UK-listed and only recently moved to the LSE Main Market — UK regulatory disclosure of director dealings appears in PDMR (Persons Discharging Managerial Responsibility) RNS announcements, which the snippets reference but do not enumerate exhaustively.
Industry Context
The global management consulting services market is $374.7B in 2026, projected to grow at 4.7% CAGR to $471.4B by 2031 (Mordor Intelligence). The US market is $111.4B in 2025, growing 4.11% CAGR to $160.1B by 2034 (Globe Newswire / market research). North America is 37.45% of global share. The dominant 2026 narrative across multiple industry trackers is AI/ML embedded in consulting offerings — Six Paths Consulting's "Top Trends for 2026" lead with AI, scenario modeling, and data-driven advisory. Elixirr's nine-acquisition stack (especially iOLAP, Hypothesis and TRC Advisory) maps directly onto this trend.
Competitive structure: Tier-1/tier-2 firms (McKinsey, BCG, Bain, Deloitte, KPMG, PwC, Accenture, A.T. Kearney, Oliver Wyman) account for ~60% of the market (Grand View Research). The top-10 firms account for 47% of total consulting engagements (Business Research Insights). Mid-sized players grew their share by 18% in the most recent comparable period — the structural positive for ELIX is that the mid-tier is gaining share against the big-eight, not losing it.
Boutique valuation norms: Established consulting firms trade at 6–10× EBITDA (Intelek), with top-tier specialist boutiques commanding premium multiples. Midsize financial-consulting boutiques saw EBITDA multiples of 13–15× across 2020–2025 (First Page Sage), with ~14% growth in valuation over that period. ELIX's 13× EV/EBITDA sits squarely inside the boutique-premium band.
The structural setup is favourable: a fragmented industry growing 4–5% with mid-tier share-gain dynamics, a clean reputational record, real M&A optionality funded by an $87m credit line, and a founder-led team that has delivered 4.8× from IPO. The tactical questions are who is selling in the $15.9m placing, whether the founder stake erosion continues, and whether the FY2026 guide can sustain the premium 13× EV/EBITDA.